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Squamous Cell Carcinoma, Keratoacanthoma-type Within a Tattoo
Elise Grgurich, DO, Nektarios Lountzis, MD, and Stephen Purcell, DO
Lehigh Valley Health Network, Allentown, Pennsylvania

Case Presentation:

Discussion:

Patient: 64 year-old Caucasian male.
History of Present Illness: Patient
presents with new growths on his right outer leg that have
been present for four months. Lesions appeared within
the red ink portion of his tattoo. He admits to burning
sensation if touched but denies itching and bleeding.
Patient tried using antibiotic ointment which he believes
made the lesions larger.
Medical History/Surgical History: Four
cutaneous squamous cell carcinomas with two being the
keratoacanthoma type, emphysema, hepatitis C, coronary
artery disease, myocardial infarction, cerebral vascular
accident, tonsillectomy, inguinal hernia s/p herniorrhaphy
Medications: Apixaban, esomeprazole, and
tiotropium inhaled
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.....

Fig. 1

Fig. 2

Figure 1: Two crateriform, keratotic nodules located within red tattoo pigment on the right lateral
lower leg, proximal superior and proximal posterior measuring 8 mm and 9 mm respectively.
Figure 2: A 1.1 cm crateriform, keratotic nodule located within the red pigment of the tattoo on the
right lateral lower leg, anterior.

Previous Treatments: Wide local surgical
excision and excisional biopsies
Physical Examination: There is a large tattoo
comprised predominantly of red ink on the right anterior
leg. Within the red portion of the tattoo are four scattered
erythematous, crateriform, keratotic papules and nodules
ranging in size from 0.6-1.1 cm.
Studies: Advanced Dermatology Associates, LTD.
(AD15-00774, 1/21/2015) 1. Right inferior lateral lower
leg: “Well-differentiated squamous cell carcinoma,
keratoacanthoma type, involving the reticular dermis and
transected at the base of the specimen.”
(AD15-01682, 2/13/2015) 2. Right lateral lower leg,
anterior; 3. Right lateral lower leg, proximal posterior;
4. Right lateral lower leg, proximal superior: “Atypical
squamous proliferation, consistent with early evolving
or regressing well-differentiated, invasive squamous
cell carcinoma, keratoacanthoma-type, with adjacent
superficial dermal and focal intracorneal red tattoo
pigment, completely excised. AFB-Fite, Gram, PAS,
and GMS were each performed and were negative for
infectious organisms.”
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Fig. 3 (4x)
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Fig. 4 (10x)
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Fig. 5 (40x)

Figure 3: Atypical squamous proliferation consistent with keratoacanthoma. Note the red tattoo pigment
embedded in the apex of the cutaneous horn (see arrow).
Figure 4: Atypical cystic squamous proliferation with notable red tattoo pigment in the surrounding dermis
and focally embedded in the cutaneous horn (see arrows).
Figure 5: High power view of red tattoo pigment embedded in the apex of the cutaneous horn.
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Keratoacanthoma (KA) is a common keratinizing squamous cell neoplasm characterized
by rapid growth and spontaneous involution. Though the origin is not completely
understood, ultraviolet light, carcinogenic exposure, genetics, immunosuppression, viral
infection and trauma have been associated with development of KA. Tattoo-induced KA
is less commonly reported. It typically presents as a rapidly enlarging crateriform nodule
most commonly on sun-exposed skin. Clinically the lesion may resemble a viral verruca,
squamous cell carcinoma, and mycobacterial or fungal infection.
Histopathologically, KA demonstrates a well-circumscribed, keratin-filled invagination
of the epidermis with hyperkeratosis, parakeratosis, and acanthosis. Atypical squamous
cells may be present but cellular atypia is less remarkable as the lesion matures.
Histopathological differential includes pseudoepitheliomatous hyperplasia, squamous
cell carcinoma (SCC), and verrucous carcinoma. Pseudoepitheliomatous hyperplasia is
a similar appearing, rapidly growing lesion that is often difficult to distinguish from KA;
histopathological correlation is required for diagnosis. A history of rapid growth and
development may help distinguish KA and SCC clinically.
Most cutaneous reactions associated with tattoos occur within red ink. A case series of 11
KAs associated with tattoos demonstrated that 82% were within or in close proximity to
red ink. Mercuric sulfide (cinnabar), sienna (ferric hydrate), sandalwood, brazilwood, and
organic pigments (aromatic azoic compounds) have all been found in red ink. Mercury
compounds were eliminated in 1976 because of its potential carcinogenicity. However,
some organic colorants (azo compounds) that were classified as carcinogenic remain in
current ink products.
Approximately 50 skin cancers in tattoos have been reported in the past 40 years, 23 of
which presented as SCC and KA. In the past few years there has been an increase in the
incidence of isolated and eruptive KAs within tattoos. Potential mechanisms of induction
have been proposed and include trauma from the tattoo procedure, introduction of
potential carcinogenic compounds, and sun-exposure. However, with such a low number
of reported skin cancers arising in tattoos some consider the association between tattoos
and skin cancer coincidental. Despite the elusive pathogenesis of this phenomenon,
the presence of intracorneal red tattoo pigment within the squamous proliferations in
our specimens raises the possibility that the lesions could represent a reactive form of
transepidermal elimination of the tattoo pigment.
Primary management of these lesions includes complete surgical excision. Careful longterm follow-up is recommended to monitor for recurrence or presence of new lesions.
Though larger studies are needed to determine the actual causation of skin cancer within
tattoos, patient education on the potential health effects of tattooing and implementation
of regulations regarding ink manufacturing is necessary in the meantime.
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